EUVIMEDEUVIMED entdecken
Open Access

β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer

Shan Liu, Puneeth Guruprasad, Ranjani Ramasubramanian, Bhoomi Madhu, Luca Paruzzo, Kecheng Han, Andre Kelly, Alexander Shestov, He N Xu, Alberto Carturan, Chaoting Zhou, Kevin R Amses und 36 weitere

Cell · 2026-03 · 189 (6) · 1701-1716.e24

DOI: 10.1016/j.cell.2026.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-03. Verfasst von Shan Liu und 47 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology and…. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, T-Lymphocytes, Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Blood Cancer United, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The influence of lifestyle factors, such as diet, on the effectiveness of T cell-mediated cancer immunotherapies remains unclear. Here, we demonstrate that the ketogenic diet (KD)-induced ketone metabolite β-hydroxybutyrate (BHB) augments chimeric antigen receptor (CAR) T cell function across multiple preclinical cancer models. Mechanistically, BHB supports the tricarboxylic acid (TCA) cycle in CAR T cells, driving oxidative phosphorylation and energy generation. This metabolic enhancement is associated with CAR T cell proliferation and cytokine production, thereby leading to superior tumor control. Furthermore, BHB induces global transcriptional and epigenetic reprogramming in activated CAR T cells, which promotes an enhanced effector and metabolic profile. Lastly, in a prospective cohort of healthy volunteers, administration of BHB enhanced peripheral T cell oxygen consumption, mitochondrial membrane potential, and ATP production. Our results suggest that metabolite intervention via BHB supplementation is a promising, readily implementable strategy to improve adoptive T cell function against various cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-Hydroxybutyric AcidT-LymphocytesNeoplasmsReceptors, Chimeric AntigenHumansAnimalsDiet, KetogenicOxidative PhosphorylationImmunotherapy, AdoptiveCitric Acid CycleMiceCell ProliferationOxygen ConsumptionCell Line, TumorFemaleMembrane Potential, MitochondrialMetabolic Reprogramming

Stichwörter der Autor:innen

CAR T cellcancer therapyketogenic dietmetabolismoxidative phosphorylationβ-hydroxybutyrate

Substanzen

3-Hydroxybutyric AcidReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine at the…
  • Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman…
  • Department of Pathology, Stanford University, Palo Alto, CA, USA; Arc Institute, Palo Alto, CA, USA.
  • Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia,…
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Förderung

  • NCI NIH HHS
  • Blood Cancer United
  • National Institutes of Health

Zitieren

APA

Liu, S., Guruprasad, P., Ramasubramanian, R., Madhu, B., Paruzzo, L., Han, K., Kelly, A., Shestov, A., Xu, H. N., Carturan, A., Zhou, C., Amses, K. R., Afriat, A., Litichevskiy, L., Lin, J., Dubowitz, E., Tangal, N., Zhang, J., McSween, A., …, & Ruella, M. (2026). β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer. Cell, 189(6), 1701-1716.e24. https://doi.org/10.1016/j.cell.2026.02.004

Vancouver

Liu S, Guruprasad P, Ramasubramanian R, Madhu B, Paruzzo L, Han K, et al. β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer. Cell. 2026;189(6):1701-1716.e24. doi:10.1016/j.cell.2026.02.004

BibTeX
@article{Liu2026,
  author = {Liu, Shan and Guruprasad, Puneeth and Ramasubramanian, Ranjani and Madhu, Bhoomi and Paruzzo, Luca and Han, Kecheng and Kelly, Andre and Shestov, Alexander and Xu, He N and Carturan, Alberto and Zhou, Chaoting and Amses, Kevin R and Afriat, Amichay and Litichevskiy, Lev and Lin, Jason and Dubowitz, Ezra and Tangal, Neil and Zhang, Jing and McSween, Alana and Tan, Melody and Stella, Federico and Lee, Andrew and Nason, Siena and Hua, Xianxin and Schneider, Michael and Sleeman, Madeleine and Zhang, Yunlin and Gabrielli, Giulia and Yang, Ziqi and Pajarillo, Raymone and Patel, Ruchi and Ghilardi, Guido and Patel, Vrutti and Joshi, Akshita and Jiang, Shunzhou and Jiang, Yanqing and Porazzi, Patrizia and Tchou, Julia C and Keith, Brian and Li, Mingyao and Chong, Elise and Schuster, Stephen J and Milone, Michael and Rabinowitz, Joshua and O'Connor, Roddy S and Thaiss, Christoph A and Levy, Maayan and Ruella, Marco},
  title = {β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {6},
  pages = {1701--1716.e24},
  doi = {10.1016/j.cell.2026.02.004}
}
Kostenlos starten →